Literature DB >> 10828064

WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.

B Xu1, J M English, J L Wilsbacher, S Stippec, E J Goldsmith, M H Cobb.   

Abstract

We have cloned and characterized a novel mammalian serine/threonine protein kinase WNK1 (with no lysine (K)) from a rat brain cDNA library. WNK1 has 2126 amino acids and can be detected as a protein of approximately 230 kDa in various cell lines and rat tissues. WNK1 contains a small N-terminal domain followed by the kinase domain and a long C-terminal tail. The WNK1 kinase domain has the greatest similarity to the MEKK protein kinase family. However, overexpression of WNK1 in HEK293 cells exerts no detectable effect on the activity of known, co-transfected mitogen-activated protein kinases, suggesting that it belongs to a distinct pathway. WNK1 phosphorylates the exogenous substrate myelin basic protein as well as itself mostly on serine residues, confirming that it is a serine/threonine protein kinase. The demonstration of activity was striking because WNK1, and its homologs in other organisms lack the invariant catalytic lysine in subdomain II of protein kinases that is crucial for binding to ATP. A model of WNK1 using the structure of cAMP-dependent protein kinase suggests that lysine 233 in kinase subdomain I may provide this function. Mutation of this lysine residue to methionine eliminates WNK1 activity, consistent with the conclusion that it is required for catalysis. This distinct organization of catalytic residues indicates that WNK1 belongs to a novel family of serine/threonine protein kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828064     DOI: 10.1074/jbc.275.22.16795

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  204 in total

1.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport.

Authors:  Chao-Ling Yang; Jordan Angell; Rose Mitchell; David H Ellison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.

Authors:  Juliette Hadchouel; Christelle Soukaseum; Cara Büsst; Xiao-ou Zhou; Véronique Baudrie; Tany Zürrer; Michelle Cambillau; Jean-Luc Elghozi; Richard P Lifton; Johannes Loffing; Xavier Jeunemaitre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

3.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

4.  Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.

Authors:  Celine Delaloy; Jingyu Lu; Anne-Marie Houot; Sandra Disse-Nicodeme; Jean-Marie Gasc; Pierre Corvol; Xavier Jeunemaitre
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor.

Authors:  Paloma H Giangrande; Timothy C Hallstrom; Chainarong Tunyaplin; Kathryn Calame; Joseph R Nevins
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

6.  WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.

Authors:  Kristopher T Kahle; Ignacio Gimenez; Hatim Hassan; Frederick H Wilson; Robert D Wong; Biff Forbush; Peter S Aronson; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade.

Authors:  Jian Xie; Joonho Yoon; Sung-Sen Yang; Shih-Hua Lin; Chou-Long Huang
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

8.  Overexpression of WNK1 in POMC-expressing neurons reduces weigh gain via WNK4-mediated degradation of Kir6.2.

Authors:  Woo Young Chung; Jung Woo Han; Woon Heo; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2018-02-01       Impact factor: 3.396

Review 9.  The WNK signaling pathway and salt-sensitive hypertension.

Authors:  Taisuke Furusho; Shinichi Uchida; Eisei Sohara
Journal:  Hypertens Res       Date:  2020-04-14       Impact factor: 3.872

10.  Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.

Authors:  Chibo Hong; K Scott Moorefield; Peter Jun; Kenneth D Aldape; Samir Kharbanda; Heidi S Phillips; Joseph F Costello
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.